Syngen Biotech Co.,Ltd. (TPEX:8279)

Syngen Biotech Revenue

In the year 2025, Syngen Biotech had annual revenue of 2.14B TWD with 6.10% growth. Syngen Biotech had revenue of 479.78M in the quarter ending December 31, 2025, with 1.05% growth.

• Revenue: 2.14B
• Revenue Growth: +6.10%
• P/S Ratio: 1.47
• Revenue / Employee: 8.65M
• Employees: 247
• Market Cap: 3.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.14B	122.89M	6.10%
Dec 31, 2024	2.01B	176.41M	9.60%
Dec 31, 2023	1.84B	-93.41M	-4.84%
Dec 31, 2022	1.93B	459.33M	31.22%
Dec 31, 2021	1.47B	159.83M	12.19%